Drug · DIN 02455013
RIVA-FINASTERIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 27, 2024; first marketed June 16, 2016.
- Drug Identification Number (DIN)
- 02455013
- Company (DIN owner)
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Finasteride G04CB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FINASTERIDE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 28, 2024: NOC 33529Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers. Administratif: Accord de licence entre deux fabricants
- June 1, 2016: NOC 18149Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named RIVA-FINASTERIDE
- DIN 02549204 · Approved